KPV 5mg Research Peptide

KPV 5mg is a synthetic tripeptide research compound composed of lysine–proline–valine, representing the C-terminal fragment of alpha-melanocyte–stimulating hormone (alpha-melanocyte stimulating hormone). This fragment, commonly referred to as KPV peptide, has been studied in laboratory and preclinical settings for its potential involvement in inflammatory signaling pathways, immune modulation, and gastrointestinal-related research models. KPV 5mg is supplied as a lyophilized powder with a reported purity greater than 99% and is intended exclusively for laboratory research use.

What Is KPV 5mg?

KPV 5mg is derived from amino acids 11–13 of alpha-melanocyte–stimulating hormone, a naturally occurring peptide involved in multiple biological processes. Researchers identified that this short fragment retains many of the signaling properties of the full-length hormone without engaging all melanocortin receptor pathways. As a result, KPV has been investigated as a focused research tool for studying inflammatory and immune-related signaling mechanisms.

KPV 5mg is an experimental research peptide and is not approved for human or animal use.

Research Background

KPV was first described in scientific literature in 1989 as the key messenger sequence of alpha-melanocyte–stimulating hormone. Early experimental studies examined its role in regulating vascular permeability and localized swelling. Subsequent research expanded interest in KPV due to observations suggesting involvement in immune regulation and inflammatory pathway modulation.

Preclinical and animal studies have explored KPV in models related to gastrointestinal inflammation, immune cell signaling, and tissue response to inflammatory stress. All findings remain preclinical and have not been validated in human clinical trials.

Mechanisms of Research Interest

Inflammatory Pathway Modulation

KPV 5mg has been studied for its potential ability to influence inflammatory signaling cascades, including downregulation of pro-inflammatory cytokine expression in experimental models.

Immune System Regulation

Research suggests KPV may interact with immune cells to help regulate excessive inflammatory responses, making it a compound of interest in immune balance research.

Gastrointestinal Research Models

Murine studies have examined KPV for its potential role in reducing inflammatory cell infiltration and supporting intestinal function in experimental models of bowel-related dysfunction.

Tissue and Vascular Research

KPV has been investigated for its involvement in controlling localized swelling and vascular permeability, particularly in inflammation-focused research settings.

All mechanisms described are experimental observations or theoretical models and do not imply clinical or therapeutic benefit.

Molecular and Chemical Information

• Product Name: KPV 5mg

• Form: Lyophilized powder

• Purity: Greater than 99%

• Peptide Length: 3 amino acids (tripeptide)

• Amino Acid Sequence: Lysine–Proline–Valine

• Molecular Formula: C16H30N4O4

• Molecular Weight: 342.43 g/mol

• Alternate Names: MSH (11–13), ACTH (11–13), alpha-melanocyte stimulating hormone (11–13)

Research Applications

KPV 5mg may be utilized by qualified researchers in laboratory investigations involving:

• Inflammatory signaling pathway research

• Immune modulation and cytokine studies

• Gastrointestinal and intestinal inflammation models

• Tissue protection and vascular response research

All use must remain within controlled laboratory environments.

Regulatory Status and Use Disclaimer

• For research use only

• Not approved by the Food and Drug Administration

• Not intended for human or veterinary use

• Not intended to diagnose, treat, cure, or prevent any disease

• No established clinical safety, dosing, or efficacy data